Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy
Oncolytics Biotech announced published data demonstrating that its investigational immunotherapy pelareorep can convert immunologically inactive (cold) liver cancer tumors into immunologically active (hot) tumors, potentially making them more responsive to immune-based therapies. The publication highlights pelareorep's ability to upregulate inflamm…